Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts

Journal of Cellular Biochemistry

Volumn 115, Issue 7, 2014, Pages 1290-1298

  Khan, Usman A ^a   Hashimi, Saeed M ^a   Khan, Shershah ^a   Quan, Jingjing ^a   Bakr, Mahmoud M ^a   Forwood, Mark R ^a   Morrison, Nigel M ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

CCR2; CTSK; FBGCs; GM CSF; IL 4; M CSF; MCP1; MMP9; OSTEOCLASTS; RANKL; TRAP

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEINASE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ACID PHOSPHATASE; CTSK PROTEIN, MOUSE; ISOENZYME; MMP9 PROTEIN, MOUSE; NFATC1 PROTEIN, MOUSE; PEPTIDE HYDROLASE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; GENE EXPRESSION; GENE SEQUENCE; GIANT CELL; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; PERIIMPLANTITIS;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CATHEPSIN K; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; GIANT CELLS, FOREIGN-BODY; ISOENZYMES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PEPTIDE HYDROLASES; PERI-IMPLANTITIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CHEMOKINE;

EID: 84900029811     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24781     Document Type: Article

References (56)

1. Al-Nawas B, Kammerer PW, Morbach T, Ladwein C, Wegener J, Wagner W,. 2012. Ten-year retrospective follow-up study of the TiOblast dental implant. Clin Implant Dent Relat Res 14: 127-134.
2. Anderson JM, Rodriguez A, Chang DT,. 2008. Foreign body reaction to biomaterials. Semin Immunol 20: 86-100.
3. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM, Mack M, Erben RG, Smolen JS, Redlich K,. 2009. Estrogen-dependent and CC chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 15: 417-424.
4. Boissy P, Machuca I, Pfaff M, Ficheux D, Jurdic P,. 1998. Aggregation of mononucleated precursors triggers cell surface expression of alphavbeta3 integrin, essential to formation of osteoclast-like multinucleated cells. J Cell Sci 111 (17): 2563-2574.
5. Burstone MS,. 1959. Histochemical demonstration of acid phosphatase activity in osteoclasts. J Histochem Cytochem 7: 39-41.
6. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M,. 2002. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J Biol Chem 277: 21971-21982.
7. Chellaiah MA, Hruska KA,. 2003. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72: 197-205.
8. Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M,. 2000. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96: 671-675.
9. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J,. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412-2424.
10. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M,. 1996. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271: 12511-12516.
11. Ferreira SB, Jr., Repeke CE, Raimundo FM, Nunes IS, Avila-Campos MJ, Ferreira BR, Santana da Silva J, Campanelli AP, Garlet GP,. 2011. CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction. J Dent Res 90: 632-637.
12. Fransson C, Wennstrom J, Tomasi C, Berglundh T,. 2009. Extent of peri-implantitis-associated bone loss. J Clin Periodontol 36: 357-363.
13. Hancock WW, Gao W, Faia KL, Csizmadia V,. 2000. Chemokines and their receptors in allograft rejection. Curr Opin Immunol 12: 511-516.
14. Hara T, Bacon KB, Cho LC, Yoshimura A, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Schall TJ, Miyajima A,. 1995. Molecular cloning and functional characterization of a novel member of the CC chemokine family. J Immunol 155: 5352-5358.
15. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, Lopez CM, Adams BE, Nicholson GC,. 2004. Osteoclastic potential of human CFU-GM: Biphasic effect of GM-CSF. J Bone Miner Res 19: 190-199.
16. Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Moskalewski S,. 2011. Influence of LPS, TNF, TGF-ss1 and IL-4 on the expression of MMPs, TIMPs and selected cytokines in rat synovial membranes incubated in vitro. Int J Mol Med 27: 127-137.
17. Jones JA, Chang DT, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM,. 2007. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 83: 585-596.
18. Khan UA, Hashimi SM, Bakr MS, Forwood MR, Morrison NA,. 2013. Foreign body giant cells and osteoclasts are TRAP positive, have podosome-belts and both require OC-STAMP for cell fusion. J Cell Biochem 114 (8): 1772-1778.
19. Klinge B, Hultin M, Berglundh T,. 2005. Peri-implantitis. Dent Clin North Am 49 (661-76): vii-viii.
20. Konttinen YT, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O,. 2006. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 26: 135-141.
21. Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P,. 2004. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165: 2157-2166.
22. Lean JM, Murphy C, Fuller K, Chambers TJ,. 2002. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 87: 386-393.
23. Lubberts E, Joosten LA, Chabaud M, van Den Bersselaar L, Oppers B, Coenen-De Roo CJ, Richards CD, Miossec P, van Den Berg WB,. 2000. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 105: 1697-1710.
24. MacLauchlan S, Skokos EA, Meznarich N, Zhu DH, Raoof S, Shipley JM, Senior RM, Bornstein P, Kyriakides TR,. 2009. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. J Leukoc Biol 85: 617-626.
25. Maruotti N, Grano M, Colucci S, d'Onofrio F, Cantatore FP,. 2011. Osteoclastogenesis and arthritis. Clin Exp Med 11: 137-145.
26. Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y,. 2004. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU. 1. J Biol Chem 279: 45969-45979.
27. Maurer M, von Stebut E,. 2004. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36: 1882-1886.
28. McNally AK, Anderson JM,. 1995. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 147: 1487-1499.
29. Miller KM, Anderson JM,. 1989. In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers. J Biomed Mater Res 23: 911-930.
30. Miyamoto K, Ninomiya K, Sonoda KH, Miyauchi Y, Hoshi H, Iwasaki R, Miyamoto H, Yoshida S, Sato Y, Morioka H, Chiba K, Egashira K, Suda T, Toyama Y, Miyamoto T,. 2009. MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. Biochem Biophys Res Commun 383: 373-377.
31. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T,. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
32. Mombelli A,. 2002. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol 2000 28: 177-189.
33. Moreno JL, Kaczmarek M, Keegan AD, Tondravi M,. 2003. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: Irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086.
34. Nuss KM, von Rechenberg B,. 2008. Biocompatibility issues with modern implants in bone-a review for clinical orthopedics. Open Orthop J 2: 66-78.
35. Oba Y, Lee JW, Ehrlich LA, Chung HY, Jelinek DF, Callander NS, Horuk R, Choi SJ, Roodman GD,. 2005. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol 33: 272-278.
36. Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P,. 2004. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol 173: 2084-2090.
37. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M,. 2003. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111: 1185-1199; quiz 1200.
38. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF,. 1996. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11: 150-159.
39. Petkovic-Curcin A, Matic S, Vojvodic D, Stamatovic N, Todorovic T,. 2011. Cytokines in pathogenesis of peri-implantitis. Vojnosanit Pregl 68: 435-440.
40. Petkovic AB, Matic SM, Stamatovic NV, Vojvodic DV, Todorovic TM, Lazic ZR, Kozomara RJ,. 2010. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 39: 478-485.
41. Poltorak AN, Bazzoni F, Smirnova II, Alejos E, Thompson P, Luheshi G, Rothwell N, Beutler B,. 1995. MIP-1 gamma: Molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J Inflamm 45: 207-219.
42. Qin S, LaRosa G, Campbell JJ, Smith-Heath H, Kassam N, Shi X, Zeng L, Buthcher EC, Mackay CR,. 1996. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: Correlation with transendothelial chemotactic potential. Eur J Immunol 26: 640-647.
43. Quinn JM, Whitty GA, Byrne RJ, Gillespie MT, Hamilton JA,. 2002. The generation of highly enriched osteoclast-lineage cell populations. Bone 30: 164-170.
44. Repeke CE, Ferreira SB, Jr., Claudino M, Silveira EM, de Assis GF, Avila-Campos MJ, Silva JS, Garlet GP,. 2010. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 46: 1122-1130.
45. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K,. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124: 1091-1102.
46. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K,. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95: 13453-13458.
47. Schall TJ, Bacon K, Toy KJ, Goeddel DV,. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
48. Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N,. 2009. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583: 2435-2440.
49. Spessotto P, Rossi FM, Degan M, Di Francia R, Perris R, Colombatti A, Gattei V,. 2002. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol 158: 1133-1144.
50. Stein NC, Kreutzmann C, Zimmermann SP, Niebergall U, Hellmeyer L, Goettsch C, Schoppet M, Hofbauer LC,. 2008. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway. J Bone Miner Res 23: 750-758.
51. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV,. 2007. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313: 168-178.
52. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T,. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901.
53. Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M,. 2010. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol 81: 99-108.
54. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE,. 1998. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 89: 44-53.
55. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T,. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345-351.
56. Yu X, Huang Y, Collin-Osdoby P, Osdoby P,. 2004. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19: 2065-2077.